Journal article · Clinical audiology← The news desk

✦ The Dispatch

Ultrasound-Guided Intra-Articular Infiltration of Hyaluronic Acid, Lidocaine, and Methylprednisolone in Patients with Temporomandibular Disorders (TMD): A Preliminary Pilot Case Series

A dispatch from PubMed — filed

/OBJECTIVES: This preliminary pilot case series aims to evaluate the feasibility and temporal evolution of pain and function following an ultrasound-guided infiltration technique with hyaluronic acid and methylprednisolone in a specific patient population with Temporomandibular Disorders (TMD) characterized by MRI-confirmed retrodiscal tissue hyperemia....

Clinical Takeaway

No actionable change — this is a preliminary pilot case series with no control group; results cannot yet support changes to TMD injection protocols.

Why It Matters

TMD commonly co-presents in audiology clinics as ear pain and tinnitus, so preliminary evidence on injection-based management is of background interest to audiologists managing complex ear-symptom cases.

Key Points
  1. 01Pilot case series with no control group; evidence is very preliminary.
  2. 02Ultrasound guidance was used to ensure accurate intra-articular needle placement.
  3. 03Combination of hyaluronic acid, lidocaine, and methylprednisolone was injected into the jaw joint.
  4. 04Outcomes included pain levels and jaw function measures.
  5. 05Results cannot be generalised without larger controlled trials.
Claims & Evidence

Ultrasound-guided intra-articular infiltration of hyaluronic acid, lidocaine, and methylprednisolone improves pain and function in TMD patients.

studypartially supported
Research metadata
PMID
42346194
DOI
10.3390/clinpract16060111.
Journal
Clinics and Practice
Publication type
case_report
Evidence level
4
Population
Patients diagnosed with temporomandibular disorders (TMD)
Intervention
Ultrasound-guided intra-articular infiltration of hyaluronic acid, lidocaine, and methylprednisolone

Primary outcomes

Pain reduction; Jaw function improvement

Related stories